1. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI
    XIAOXIAO ZUO et al, 2014, Oncology Reports CrossRef
  2. Multiple regulation pathways and pivotal biological functions of STAT3 in cancer
    Jie Yuan et al, 2015, Scientific Reports CrossRef
  3. Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI
    Kaishan Ye et al, 2016, Cancer Science CrossRef
  4. The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis
    Peng Gao et al, 2017, Oncotarget CrossRef
  5. Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
    Yubin Lei et al, 2017, Molecular Cancer CrossRef
  6. The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3
    Giovanni Gambi et al, 2019, Cancer Research CrossRef
  7. Epigenetic inhibition of the tumor suppressor ARHI by light at night‐induced circadian melatonin disruption mediates STAT3‐driven paclitaxel resistance in breast cancer
    Shulin Xiang et al, 2019, Journal of Pineal Research CrossRef
  8. Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumor
    Hyo Jin Kang et al, 2017, Oncotarget CrossRef
  9. The mechanisms of DIRAS family members in role of tumor suppressor
    Xueli Li et al, 2019, Journal of Cellular Physiology CrossRef
  10. Genetic Variants in STAT3 Promoter Regions and Their Application in Molecular Breeding for Body Size Traits in Qinchuan Cattle
    Sen Wu et al, 2018, International Journal of Molecular Sciences CrossRef
  11. Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1
    YONGGUANG LI et al, 2013, Oncology Reports CrossRef
  12. Noncanonical pS727 post translational modification dictates major STAT3 activation and downstream functions in breast cancer
    Shalini Dimri et al, 2020, Experimental Cell Research CrossRef
  13. Revisiting STAT3 signalling in cancer: new and unexpected biological functions
    Hua Yu et al, 2014, Nature Reviews Cancer CrossRef
  14. Molecular mechanism of mammary gland involution: An update
    Manoj Kumar Jena et al, 2019, Developmental Biology CrossRef
  15. Targeting the tumor and its associated stroma: One and one can make three in adoptive T cell therapy of solid tumors
    Anna Mondino et al, 2017, Cytokine & Growth Factor Reviews CrossRef
  16. The Role of Methylation in the CpG Island of the ARHI Promoter Region in Cancers
    Xiaozhuan Liu et al, 2020, Single-cell Sequencing and Methylation CrossRef
  17. STAT3 in the dorsal raphe gates behavioural reactivity and regulates gene networks associated with psychopathology
    Sonali N. Reisinger et al, 2021, Molecular Psychiatry CrossRef
  18. Targeting STAT3 in cancer and autoimmune diseases
    Tohid Gharibi et al, 2020, European Journal of Pharmacology CrossRef
  19. S-Phase Cell Cycle Arrest, Apoptosis, and Molecular Mechanisms of Aplasia Ras homolog Member I–Induced Human Ovarian Cancer SKOV3 Cell Lines
    Qiaoying Zhu et al, 2014, International Journal of Gynecologic Cancer CrossRef
  20. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial–mesenchymal transition
    Hong Liu et al, 2015, Carcinogenesis CrossRef
  21. Essential Role of DNA Methyltransferase 1–mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors
    Hye-Young Min et al, 2017, Clinical Cancer Research CrossRef
  22. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma
    Ping Zhang et al, 2020, Clinical Epigenetics CrossRef